BioLife Solutions Inc
BLFS26.280USD
+0.695+2.72%
Close 09/18, 16:00（ET）Quotes delayed by 15 min
1.26BMarket Cap
LossP/E TTM
More Details of BioLife Solutions Inc Company
BioLife Solutions, Inc. is a supplier of cell processing tools and services for the cell and gene therapy (CGT) market. The Company facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the regenerative medicine market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal cryogenic vials, which are rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Company’s ThawSTAR product line is composed of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.
Company Info
Ticker SymbolBLFS
Company nameBioLife Solutions Inc
IPO dateNov 22, 1989
CEOMr. Roderick De Greef
Number of employees159
Security typeOrdinary Share
Fiscal year-endNov 22
AddressSuite 310
CityBOTHELL
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code98021
Phone14254011400
Websitehttps://www.biolifesolutions.com/
Ticker SymbolBLFS
IPO dateNov 22, 1989
CEOMr. Roderick De Greef
Company Executives
Name
Name/Position
Position
Shareholding
Change
Dr. Aby J. Mathew, Ph.D.
Dr. Aby J. Mathew, Ph.D.
Chief Scientific Officer, Executive Vice President
Chief Scientific Officer, Executive Vice President
253.93K
-0.25%
Ms. Karen A. Foster
Ms. Karen A. Foster
Chief Quality and Operations Officer
Chief Quality and Operations Officer
150.94K
-0.34%
Mr. Roderick De Greef
Mr. Roderick De Greef
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
118.82K
-48.71%
Mr. Troy Wichterman
Mr. Troy Wichterman
Chief Financial Officer
Chief Financial Officer
100.16K
-1.02%
Mr. Todd Berard
Mr. Todd Berard
Chief Commercial Officer
Chief Commercial Officer
98.49K
-0.31%
Ms. Sarah Aebersold
Ms. Sarah Aebersold
Chief Human Resources Officer
Chief Human Resources Officer
50.39K
-1.84%
Mr. Joydeep Goswami
Mr. Joydeep Goswami
Independent Director
Independent Director
41.11K
-14.33%
Sean Werner
Sean Werner
Chief Technology Officer
Chief Technology Officer
26.31K
-0.27%
Ms. Amy Duross
Ms. Amy Duross
Lead Independent Director
Lead Independent Director
23.81K
-22.41%
Ms. Catherine (Cathy) Coste, CPA
Ms. Catherine (Cathy) Coste, CPA
Independent Director
Independent Director
5.70K
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Aby J. Mathew, Ph.D.
Dr. Aby J. Mathew, Ph.D.
Chief Scientific Officer, Executive Vice President
Chief Scientific Officer, Executive Vice President
253.93K
-0.25%
Ms. Karen A. Foster
Ms. Karen A. Foster
Chief Quality and Operations Officer
Chief Quality and Operations Officer
150.94K
-0.34%
Mr. Roderick De Greef
Mr. Roderick De Greef
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
118.82K
-48.71%
Mr. Troy Wichterman
Mr. Troy Wichterman
Chief Financial Officer
Chief Financial Officer
100.16K
-1.02%
Mr. Todd Berard
Mr. Todd Berard
Chief Commercial Officer
Chief Commercial Officer
98.49K
-0.31%
Ms. Sarah Aebersold
Ms. Sarah Aebersold
Chief Human Resources Officer
Chief Human Resources Officer
50.39K
-1.84%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Product Revenue-Cell processing
21.57M
90.11%
Rental Revenue- Evo and thaw
1.58M
6.61%
Product Revenue- Evo and thaw
725.00K
3.03%
Service Revenue-Evo and thaw
60.00K
0.25%
No Data
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Product Revenue-Cell processing
21.57M
90.11%
Rental Revenue- Evo and thaw
1.58M
6.61%
Product Revenue- Evo and thaw
725.00K
3.03%
Service Revenue-Evo and thaw
60.00K
0.25%
Shareholding Stats
Updated: Sat, Aug 16
Updated: Sat, Aug 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Casdin Capital, LLC
14.00%
BlackRock Institutional Trust Company, N.A.
10.61%
T. Rowe Price Investment Management, Inc.
8.86%
Invesco Advisers, Inc.
7.22%
The Vanguard Group, Inc.
6.03%
Other
53.28%
Shareholders
Shareholders
Proportion
Casdin Capital, LLC
14.00%
BlackRock Institutional Trust Company, N.A.
10.61%
T. Rowe Price Investment Management, Inc.
8.86%
Invesco Advisers, Inc.
7.22%
The Vanguard Group, Inc.
6.03%
Other
53.28%
Shareholder Types
Shareholders
Proportion
Investment Advisor
48.06%
Investment Advisor/Hedge Fund
34.39%
Hedge Fund
17.27%
Research Firm
2.46%
Individual Investor
2.20%
Pension Fund
1.56%
Bank and Trust
0.68%
Sovereign Wealth Fund
0.08%
Venture Capital
0.05%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
411
47.71M
99.74%
-5.40M
2025Q1
430
51.12M
107.57%
-1.38M
2024Q4
407
48.89M
104.05%
-2.49M
2024Q3
404
46.98M
101.82%
-6.27M
2024Q2
385
48.82M
105.97%
-2.22M
2024Q1
377
46.95M
103.67%
-5.60M
2023Q4
397
47.58M
108.04%
-4.07M
2023Q3
399
45.29M
104.13%
-2.05M
2023Q2
401
44.87M
103.50%
-2.76M
2023Q1
408
43.41M
100.74%
-4.46M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Casdin Capital, LLC
7.71M
16.2%
-1.03M
-11.77%
Jun 10, 2025
BlackRock Institutional Trust Company, N.A.
5.07M
10.66%
-141.26K
-2.71%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
1.35M
2.83%
+1.35M
--
Mar 31, 2025
Invesco Advisers, Inc.
3.33M
7%
+274.55K
+8.99%
Mar 31, 2025
The Vanguard Group, Inc.
2.80M
5.88%
-32.12K
-1.14%
Mar 31, 2025
State Street Global Advisors (US)
1.43M
3.01%
-35.28K
-2.40%
Mar 31, 2025
Fred Alger Management, LLC
1.53M
3.22%
-61.10K
-3.83%
Mar 31, 2025
MFS Investment Management
764.67K
1.61%
+1.77K
+0.23%
Mar 31, 2025
Rockefeller Capital Management
964.26K
2.03%
+142.49K
+17.34%
Mar 31, 2025
Columbia Wanger Asset Management, LLC
881.34K
1.85%
+134.68K
+18.04%
Mar 31, 2025
View more
Related ETFs
Updated: Wed, Aug 6
Updated: Wed, Aug 6
Name
Proportion
Invesco S&P SmallCap Health Care ETF
0.53%
Invesco S&P SmallCap 600 Pure Growth ETF
0.52%
First Trust Multi-Manager Small Cap Opportunities ETF
0.38%
First Trust Active Factor Small Cap ETF
0.19%
iShares Micro-Cap ETF
0.18%
SPDR S&P 600 Small Cap Growth ETF
0.12%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.12%
iShares S&P Small-Cap 600 Growth ETF
0.11%
First Trust Small Cap Growth AlphaDEX Fund
0.1%
iShares ESG Select Screened S&P Small-Cap ETF
0.07%
View more
Invesco S&P SmallCap Health Care ETF
Proportion0.53%
Invesco S&P SmallCap 600 Pure Growth ETF
Proportion0.52%
First Trust Multi-Manager Small Cap Opportunities ETF
Proportion0.38%
First Trust Active Factor Small Cap ETF
Proportion0.19%
iShares Micro-Cap ETF
Proportion0.18%
SPDR S&P 600 Small Cap Growth ETF
Proportion0.12%
Vanguard S&P Small-Cap 600 Growth Index Fund
Proportion0.12%
iShares S&P Small-Cap 600 Growth ETF
Proportion0.11%
First Trust Small Cap Growth AlphaDEX Fund
Proportion0.1%
iShares ESG Select Screened S&P Small-Cap ETF
Proportion0.07%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
